mdxhealth
Steven Lombardo is a skilled Molecular Diagnostic Specialist at mdxhealth, leveraging expertise in non-invasive molecular diagnostics for prostate cancer patient stratification since May 2022. Prior experience includes roles such as Area Manager at MicroGenDX focusing on Next Generation Sequencing for infection diagnosis, and Mid-Atlantic Account Manager at MedTraxx managing medical equipment purchases across multiple specialties. Steven's leadership abilities were exemplified as Area Vice President at DermaTran Health Solutions, where a sales team was built and revenue increased from $3 million to $15 million. Previous positions include significant sales management roles at Optimal Pain Control, Boston Scientific, Integra LifeSciences, and Dynasplint Systems, with accomplishments in boosting sales and team development. Steven holds a Bachelor's degree in Mechanical Engineering from the University of Maryland.
This person is not in any offices
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.